KSHV Reactivation from Latency Requires Pim-1 and Pim-3 Kinases to Inactivate the Latency-Associated Nuclear Antigen LANA
暂无分享,去创建一个
Jussi Taipale | Markku Varjosalo | Thomas F. Schulz | J. Taipale | M. Varjosalo | T. Schulz | P. Ojala | P. Koskinen | A. Lehtonen | Eeva-Marja Rainio | Fang Cheng | Anne Lehtonen | Fang Cheng | Magdalena Weidner-Glunde | Päivi J. Koskinen | Päivi M. Ojala | E. Rainio | Magdalena Weidner-Glunde
[1] W. Zhu,et al. Potential Cellular Signatures of Viral Infections in Human Hematopoietic Cells , 2002, Disease markers.
[2] D. Ganem,et al. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. , 2004, The Journal of clinical investigation.
[3] Shou-Jiang Gao,et al. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. , 2008, Virology.
[4] D. Ganem,et al. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. , 1997, The Journal of clinical investigation.
[5] S. Dhanasekaran,et al. Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.
[6] R. Sarid,et al. An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus. , 2006, The Journal of general virology.
[7] P. Lieberman,et al. Acetylation of the Latency-Associated Nuclear Antigen Regulates Repression of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription , 2006, Journal of Virology.
[8] J. Vieira,et al. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. , 2004, Virology.
[9] S. Verma,et al. Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Inhibits Lytic Replication by Targeting Rta: a Potential Mechanism for Virus-Mediated Control of Latency , 2004, Journal of Virology.
[10] L. Rainbow,et al. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen , 1997, Journal of virology.
[11] B. Chandran,et al. Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. , 2000, The American journal of pathology.
[12] A. Haase,et al. A Cluster of Latently Expressed Genes in Kaposi’s Sarcoma-Associated Herpesvirus , 1998, Journal of Virology.
[13] Sami Kilpinen,et al. Application of Active and Kinase-Deficient Kinome Collection for Identification of Kinases Regulating Hedgehog Signaling , 2008, Cell.
[14] Jos Jonkers,et al. Mice Deficient for All PIM Kinases Display Reduced Body Size and Impaired Responses to Hematopoietic Growth Factors , 2004, Molecular and Cellular Biology.
[15] Jianhong Hu,et al. Latency-associated Nuclear Antigen (LANA) Cooperatively Binds to Two Sites within the Terminal Repeat, and Both Sites Contribute to the Ability of LANA to Suppress Transcription and to Facilitate DNA Replication* , 2002, The Journal of Biological Chemistry.
[16] M. Corbellino,et al. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. , 2000, The American journal of pathology.
[17] F. Sigaux,et al. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[18] Shou-Jiang Gao,et al. Disruption of Kaposi's Sarcoma-Associated Herpesvirus Latent Nuclear Antigen Leads to Abortive Episome Persistence , 2004, Journal of Virology.
[19] J. Levy,et al. Induction of human herpesvirus-8 gene expression by recombinant interferon gamma. , 2000, AIDS.
[20] P. Ojala,et al. Cell signaling pathways engaged by KSHV. , 2006, Biochimica et biophysica acta.
[21] D. Ganem,et al. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. , 2002, Genes & development.
[22] P. Monini,et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. , 1999, Blood.
[23] S. Verma,et al. KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity. , 2006, Virology.
[24] T. Schulz,et al. Brd2/RING3 Interacts with a Chromatin-Binding Domain in the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 (LANA-1) That Is Required for Multiple Functions of LANA-1 , 2005, Journal of Virology.
[25] D. Dittmer,et al. Charting Latency Transcripts in Kaposi's Sarcoma-Associated Herpesvirus by Whole-Genome Real-Time Quantitative PCR , 2002, Journal of Virology.
[26] P. Monini,et al. Reactivation and role of HHV-8 in Kaposi's sarcoma initiation. , 2001, Advances in cancer research.
[27] S. Chanda,et al. Systematic Identification of Cellular Signals Reactivating Kaposi Sarcoma–Associated Herpesvirus , 2007, PLoS pathogens.
[28] Jianhong Hu,et al. DNA Binding and Modulation of Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.
[29] R. Sun,et al. Regulation of KSHV lytic gene expression. , 2007, Current topics in microbiology and immunology.
[30] K. Hagihara,et al. Viral Load of Human Herpesvirus 8 (HHV-8) in the Circulatory Blood Cells Correlates with Clinical Progression in a Patient with HHV-8-associated Solid Lymphoma with AIDS-associated Kaposi's Sarcoma , 2004, Leukemia & lymphoma.
[31] B. Ensoli,et al. Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology. , 1998, Critical reviews in oncogenesis.
[32] E. Cesarman,et al. Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases , 2002, Clinical Microbiology Reviews.
[33] Remco Dijkman,et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. , 2005, Blood.
[34] R. Sun,et al. Transcription Activation of Polyadenylated Nuclear RNA by Rta in Human Herpesvirus 8/Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.
[35] D. Dittmer. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. , 2003, Cancer research.
[36] C. Thompson,et al. The survival kinases Akt and Pim as potential pharmacological targets. , 2005, The Journal of clinical investigation.
[37] E. Kieff,et al. Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity. , 2005, Virology.
[38] M. Staudt,et al. The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. , 2007, Current topics in microbiology and immunology.
[39] T. Möröy,et al. The serine/threonine kinase Pim-1. , 2005, The international journal of biochemistry & cell biology.
[40] E. Robertson,et al. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency. , 2006, Virology.
[41] M. Ballestas,et al. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. , 1999, Science.
[42] R. Sun,et al. Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus. , 2000, The Journal of general virology.
[43] D. Dittmer,et al. Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. , 2000, Virology.
[44] J. Countryman,et al. Lytic cycle switches of oncogenic human gammaherpesviruses. , 2007, Advances in cancer research.
[45] Stefan Knapp,et al. Structure and Substrate Specificity of the Pim-1 Kinase* , 2005, Journal of Biological Chemistry.
[46] T. Schulz,et al. Human herpesvirus 8: Biology and role in the pathogenesis of Kaposi’s sarcoma and other AIDS-related malignancies , 2003, Current infectious disease reports.
[47] S. Verma,et al. Latency-Associated Nuclear Antigen (LANA) of Kaposi's Sarcoma-Associated Herpesvirus Interacts with Origin Recognition Complexes at the LANA Binding Sequence within the Terminal Repeats , 2006, Journal of Virology.